EVIO

EVIO Working Capital

The Working Capital of EVIO (EVIO) as of Nov 13, 2026 is -8.53 M USD. In the previous year, Working Capital was -16.59 M USD — a change of -48.58% (higher).

Working Capital

-8.53 MUSD

YoY

-48.58%

Last updated:

Working Capital of EVIO is 2022 -8.53 M USD. Working Capital of EVIO was 2021 -16.59 M USD. It decreases by -48.58% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EVIO Stock analysis

What does EVIO do? EVIO, Inc. generates revenue through analytical testing services for cannabis and hemp products, targeting agricultural and pharmaceutical industries. The company operates subsidiaries including Smith Scientific Industries, LLC, Greenhaus Analytical Labs, LLC, and Viridis Analytics, LLC, which provide testing to verify regulatory compliance for product sales. Residential and commercial construction services form another revenue stream, while research and development and consulting services cater to cannabis and hemp industry participants. Subsidiaries such as EVIO Labs OR, Inc., C3 Labs, LLC, and EVIO Labs Humboldt, LLC further support the company's service offerings. The primary customers for EVIO's testing services are businesses within the cannabis and hemp sectors requiring regulatory verification. Construction services are sold to residential and commercial clients, while R&D and consulting services target industry participants seeking expertise. Subsidiaries like Keystone Labs, Inc. contribute to the analytical testing segment, ensuring compliance with market requirements. EVIO's revenue model relies on multiple service lines across different industry segments without relying on external partnerships or third-party platforms. EVIO's service portfolio includes analytical testing, construction, and consulting, with all operations managed through its subsidiaries. The company's focus on regulatory compliance for cannabis and hemp products drives demand for its testing services. Construction services provide additional revenue, while R&D and consulting support industry growth. Subsidiaries such as Smith Scientific Industries, LLC and Greenhaus Analytical Labs, LLC operate under the EVIO brand to deliver specialized services to clients in the agricultural and pharmaceutical sectors. EVIO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EVIO stock

Working Capital of EVIO is -8.53 M USD in 2022.

Working Capital of EVIO changed from -16.59 M USD to -8.53 M USD, representing a -48.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Working Capital EVIO since 2006 – with annual values, charts, and detailed analysis.

Working capital is the difference between current assets and current liabilities. Positive working capital indicates a company can meet its short-term obligations.

Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Working Capital's EVIO historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — EVIO

All Key Metrics — EVIO